Jefferies & Company Raises Mettler-Toledo International PT To $160

In a report released this morning, Jefferies & Company said that Mettler-Toledo International's MTD ROIC profile is amongst the highest in its life science research supply universe, and leverage to improve the metric further is considerable, owing to its superior pricing power, highly scalable operating infrastructure, strong asset utilization acumen, and responsible capital re-deployment philosophy. “MTD's 3Q10 EPS of $1.71 was $0.15 above consensus on considerable organic revenue upside that flowed at respectable incremental profitability rates (23%),” Jefferies & Company writes. “PT moves to $160 (from $140).” Mettler-Toledo International currently trades at $136.22.